Because applying for a patent does not necessarily mean that they will pursue Libigel for the CV benefits. They have half a dozen ambulance chasers at their door already. The last thing they want to do is put out a PR pumping the Libigel/CV angle if they are not 1000000% sure (that was not a typo, BTW) that they will go forward with it. It would be reckless of Simes to pump this patent at this point in the game, IMO. JD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.